Case number 1:20-cv-00848
Merz Pharmaceuticals, LLC et al v. Granules Pharmaceuticals, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Nov 2, 2020 | 23 | Order (2) |
| Nov 2, 2020 | 23 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,638,552; 7,816,396. (Attachments: # (1) Order)(nms) |
| Oct 30, 2020 | 22 | Order (2) Docket Text: SO ORDERED Granting [21] Joint Stipulation and Proposed Order of Dismissal Without Prejudice (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 10/30/2020. (nms) |
| Oct 30, 2020 | 21 | Stipulation of Dismissal (2) Docket Text: Joint Stipulation of Dismissal Without Prejudice, by Merz North America, Inc., Merz Pharmaceuticals, LLC. (Joyce, Alexandra) Modified on 10/30/2020 (nms). |
| Oct 21, 2020 | 20 | Redacted Document (2) Docket Text: REDACTED VERSION of [18] Stipulation by Merz North America, Inc., Merz Pharmaceuticals, LLC. (Silver, Daniel) |
| Oct 15, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: This matter has been referred to Chief Magistrate Judge Mary Pat Thynge for ADR. Counsel are to advise on or before 11/5/20 by a JOINT EMAIL to Judge Thynge, with a copy to her Judicial Administrator, Ms. Kennedy, their clients interest in mediation and the timing when mediation is preferred with a very brief explanation why. When referencing the timing for mediation, counsel rely on certain events in the scheduling order, for example, before claim construction briefing, after the close of discovery, before expert reports and the like, they are to include the date(s) on when such event(s) occur. Ordered by Chief Magistrate Judge Mary Pat Thynge on 10/15/20. (cak) |
| Oct 15, 2020 | 16 | Scheduling Order (10) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. The matter will be referred to a magistrate judge to handle all discovery disputes including any that arise in connection with expert reports. Joinder of Parties due by 6/16/2021. Amended Pleadings due by 6/16/2021. Fact Discovery completed by 8/18/2021. A Status Conference is set for 1/20/2022, at 9:00 AM in Courtroom 6A. Joint Claim Construction Brief due by 3/29/2021. A Markman Hearing is set for 4/14/2021, at 8:30 AM in Courtroom 6A. A Pretrial Conference is set for 3/4/2022, at 9:00 AM in Courtroom 6A. A 3 day Bench Trial is set to start 3/14/2022, at 8:30 AM in Courtroom (see Order for further details). Signed by Judge Richard G. Andrews on 10/14/2020. (nms) |
| Oct 15, 2020 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (cak) |
| Oct 8, 2020 | 15 | Proposed Order (10) Docket Text: PROPOSED Scheduling Order, by Merz North America, Inc., Merz Pharmaceuticals, LLC. (Joyce, Alexandra) Modified on 10/8/2020 (nms). |
| Oct 5, 2020 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Rule 16(b) Telephone Conference held on 10/5/2020. Counsel for Plaintiffs: D. Silver. Counsel for Defendant: C. Hitch. (Court Reporter Heather Triozzi.) (lak) |
| Oct 2, 2020 | 14 | Letter (1) Docket Text: Letter to The Honorable Richard G. Andrews from Daniel M. Siler, Esq. regarding Dial-In Information for Telephonic Rule 16 Conference. (Silver, Daniel) |
| Oct 1, 2020 | 13 | Proposed Order (10) Docket Text: PROPOSED Scheduling Order, by Merz North America, Inc., Merz Pharmaceuticals, LLC. (Joyce, Alexandra) Modified on 10/1/2020 (nms). |
| Sep 16, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jason A. Leonard for Merz North America, Inc. and Merz Pharmaceuticals, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Sep 16, 2020 | 12 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 10/5/2020, at 2:30 PM in Chambers before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 9/16/2020. (nms) |
| Sep 15, 2020 | 10 | Certification for Jason A. Leonard (1) |
| Sep 15, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [10] MOTION for Pro Hac Vice Appearance of Attorney Jason A. Leonard, filed by Merz Pharmaceuticals, LLC, Merz North America, Inc.. Signed by Judge Richard G. Andrews on 9/15/2020. (nms) |
| Sep 15, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [11] MOTION for Pro Hac Vice Appearance of Attorney George J. Barry III and Attorney Timothy H. Kratz, filed by Granules Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 9/15/2020. (nms) |
| Sep 15, 2020 | 10 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jason A. Leonard - filed by Merz North America, Inc., Merz Pharmaceuticals, LLC. (Attachments: # (1) Certification for Jason A. Leonard)(Silver, Daniel) |
| Sep 15, 2020 | 11 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney George J. Barry III and Attorney Timothy H. Kratz - filed by Granules Pharmaceuticals, Inc.. (Dorsney, Kenneth) |
| Sep 14, 2020 | 8 | Answer to Complaint (13) Docket Text: ANSWER to [1] Complaint, by Granules Pharmaceuticals, Inc..(Dorsney, Kenneth) |
| Sep 14, 2020 | 9 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Granules India Ltd. for Granules Pharmaceuticals, Inc. filed by Granules Pharmaceuticals, Inc.. (Dorsney, Kenneth) |
| Aug 24, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [7] Unopposed Motion Extending the Time to Respond to the Complaint (*Reset Answer Deadlines: Granules Pharmaceuticals, Inc. answer due 9/14/2020). Signed by Judge Richard G. Andrews on 8/24/2020. (nms) |
| Aug 21, 2020 | 7 | Motion for Extension of Time to File Answer (2) Docket Text: Unopposed Motion Extending the Time to Respond to the Complaint - filed by Merz North America, Inc., Merz Pharmaceuticals, LLC. (Silver, Daniel) Modified on 8/24/2020 (nms). |
| Jul 2, 2020 | 6 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Merz Pharmaceuticals, LLC, Merz North America, Inc.: For Granules Pharmaceuticals, Inc. waiver sent on 7/1/2020, answer due 8/31/2020. (Silver, Daniel) |
| Jul 1, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Jun 25, 2020 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (myr) |
| Jun 24, 2020 | 1 | Exhibit A (12) |
| Jun 24, 2020 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merz Pharma GmbH & Co. KGaA, Corporate Parent Merz Pharmaceuticals GmbH, Corporate Parent Merz, Incorporated for Merz North America, Inc., Merz Pharmaceuticals, LLC filed by Merz North America, Inc., Merz Pharmaceuticals, LLC. (myr) |
| Jun 24, 2020 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,638,552 ;7,816,396. (myr) |
| Jun 24, 2020 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than May 14, 2020. Date of Expiration of Patent: August 20, 2023.Thirty Month Stay Deadline: No earlier than 11/14/2022. (myr) |
| Jun 24, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
| Jun 24, 2020 | 1 | Civil Cover Sheet (1) |
| Jun 24, 2020 | 1 | Exhibit B (12) |
| Jun 24, 2020 | 1 | Complaint* (1) |
